| 摘要 |
<p>The present invention relates generally to the use of leukaemia inhibitory factor and functionally active parts, fragments, derivatives and/or analogues thereof and pharmaceutical compositions comprising same for use in the prevention, treatment and/or prophylaxis of microbial infection in animals. More particularly, the present invention contemplates a method of preventing, treating or otherwise ameliorating the adverse effects of microbial induced sepsis and shock in mammals.</p> |
